Skip to main content
Reset

Advanced Filters

Advanced Search Help

Standard search functionality is for the search to return results that contain all words entered into the search bar.

Exact Phrase Match Search - Use quotations around a phrase to only return results that are an exact match to the search term entered. Example: "example text"

Exclusion Search - Use the minus sign to only return results that do not include your search term. -example

Either/Or Search - Use the word OR in between words to return results that include either or both words. Example: example OR test

Use advanced filters to allow you to further drill down and limit your search results! Such as selecting two dates to only display matching search results which occur on either of those days.

Search options can be combined in limited ways to increase the accuracy of your search results. Example: A search for "intellectual property" and electrochemistry.

Advanced Filters
  • Displaying 1 - 10 of 48
  • First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last
Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma with Pembrolizumab-based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-institutional Case SeriesSuccessful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma with Pembrolizumab-based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-institutional Case Series
Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma with Pembrolizumab-based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-institutional Case Series
Albert Jang, MD, Author
Tags: Member Institution Case Reports
View Poster


Abstract: JNCCN23-0456 https://jnccn.org/view/journal...



Author(s):
  • Albert Jang, MD

Tags: Member Institution Case Reports
Response to Dabrafenib and Trametinib in a Patient with an Uncommon Activating BRAF Mutation: A First in Metastatic Non-Small Cell Lung CancerResponse to Dabrafenib and Trametinib in a Patient with an Uncommon Activating BRAF Mutation: A First in Metastatic Non-Small Cell Lung Cancer
Response to Dabrafenib and Trametinib in a Patient with an Uncommon Activating BRAF Mutation: A First in Metastatic Non-Small Cell Lung Cancer
John Sharp, MD, Author
Tags: Member Institution Case Reports
View Poster


Abstract: JNCCN23-0570 https://jnccn.org/view/journal...



Author(s):
  • John Sharp, MD

Tags: Member Institution Case Reports
Retrospective Analysis of 30-day Readmission Risk in Oncology Patients
Patricia Elizabeth Litkowski, MD, Author
Tags: Member Institution Quality Improvement
View Poster


We performed a retrospective review of all cancer patients who were admitted to our institution over a 1-year period from September 2021 to September 2022 to determine overall readmission rates and to better understand reasons for readmission.

Abstract: JNCCN23-0565 https://jnccn.org/view/journal...



Author(s):
  • Patricia Elizabeth Litkowski, MD

Tags: Member Institution Quality Improvement
Implementation of Therapeutic Touch in an Ambulatory Palliative Oncology ClinicImplementation of Therapeutic Touch in an Ambulatory Palliative Oncology Clinic
Implementation of Therapeutic Touch in an Ambulatory Palliative Oncology Clinic
Jennifer Browning, MS, APRN-CNP, ACHPN, Author
Tags: Member Institution Best Practices in Implementation and Use of Clinical Practice Gu
View Poster


Abstract: JNCCN23-0531 https://jnccn.org/view/journal...



Author(s):
  • Jennifer Browning, MS, APRN-CNP, ACHPN

Tags: Member Institution Best Practices in Implementation and Use of Clinical Practice Gu
Standardizing Height and Weight Measurement for Treatment Calculations in Adult Patients with CancerStandardizing Height and Weight Measurement for Treatment Calculations in Adult Patients with Cancer
Standardizing Height and Weight Measurement for Treatment Calculations in Adult Patients with Cancer
Lisa Tesoriero, MSN, Author
Tags: Member Institution Quality Improvement
View Poster


Abstract: JNCCN23-0684 https://jnccn.org/view/journal...



Author(s):
  • Lisa Tesoriero, MSN

Tags: Member Institution Quality Improvement
Impact of Somatic Mutations on Outcomes of Salvage Radiation and Hormonal Therapy for Prostate Cancer Recurrence After ProstatectomyImpact of Somatic Mutations on Outcomes of Salvage Radiation and Hormonal Therapy for Prostate Cancer Recurrence After Prostatectomy
Impact of Somatic Mutations on Outcomes of Salvage Radiation and Hormonal Therapy for Prostate Cancer Recurrence After Prostatectomy
Keisuke T. Otani, MD, PhD, Author
Tags: Member Institution CorrelativeGenomic
View Poster


Abstract: JNCCN23-0747 https://jnccn.org/view/journal...



Author(s):
  • Keisuke T. Otani, MD, PhD

Tags: Member Institution CorrelativeGenomic
Results From the Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion-Dependent Non-del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating AgentsResults From the Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion-Dependent Non-del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents
Results From the Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion-Dependent Non-del(5q) Lower-Risk Myelodysplastic Syndromes Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents
Yazan Madanat, MD, Author
Tags: Member Institution Clinical Oncology Top Abstract
View Poster


Abstract: JNCCN23-0640 https://jnccn.org/view/journal...



Author(s):
  • Yazan Madanat, MD

Tags: Member Institution Clinical Oncology Top Abstract
Improved Access through an Integrated Supportive Care Model Reduced Urgent Care Referral and Admission Rates for Patients with Gastrointestinal MalignancyImproved Access through an Integrated Supportive Care Model Reduced Urgent Care Referral and Admission Rates for Patients with Gastrointestinal Malignancy
Improved Access through an Integrated Supportive Care Model Reduced Urgent Care Referral and Admission Rates for Patients with Gastrointestinal Malignancy
Adrianna Oraiqat, BS, Author
Tags: Member Institution Outcomes and Health Services Research Top Abstract
View Poster


Abstract: JNCCN23-0703 https://jnccn.org/view/journal...



Author(s):
  • Adrianna Oraiqat, BS

Tags: Member Institution Outcomes and Health Services Research Top Abstract
Trial in Progress: A Multi-Center Phase I Trial of Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Refractory Gastric Cancer PatientsTrial in Progress: A Multi-Center Phase I Trial of Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Refractory Gastric Cancer Patients
Trial in Progress: A Multi-Center Phase I Trial of Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Refractory Gastric Cancer Patients
Rima Nakrani, MD, MSc, Author
Tags: Member Institution ORP Trials in Progress
View Poster


Abstract: JNCCN23-0723 https://jnccn.org/view/journal...



Author(s):
  • Rima Nakrani, MD, MSc

Tags: Member Institution ORP Trials in Progress
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers: Trial in ProgressEfficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers: Trial in Progress
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers: Trial in Progress
Sierra Washington, MPH, CPH, Author
Tags: Member Institution Trials in Progress
View Poster


Abstract: JNCCN23-0631 https://jnccn.org/view/journal...



Author(s):
  • Sierra Washington, MPH, CPH

Tags: Member Institution Trials in Progress
  • Displaying 1 - 10 of 48
  • First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last